Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy
- PMID: 14675351
- DOI: 10.1046/j.1525-1438.2003.13026.x
Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy
Abstract
The aims of this study were to determine, firstly, the relationship between FIGO stage and various tumor parameters determined by magnetic resonance imaging (MRI), and, secondly, whether any of these parameters were predictors of lymph node metastases as determined by fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) in cervical cancer patients referred for radiotherapy. In 70 consecutive patients, both PET and MRI visualized all primary tumors except for one previously removed by cone biopsy. While clinical diameter and MRI-derived diameter showed a significant relationship between these two measurements (r = 0.70; P < 0.001) there was a large variability in MRI diameter for each FIGO stage and wide overlap. The average volume of primary cervical tumor on MRI was 60 cc (5-256). In FIGO stages, I, II, III and IV, uterine body involvement was present in 58%, 73%, 88%, and 100% of 19, 30, 16, and 5 patients, respectively (Ptrend= 0.015). Node positivity on FDG PET was present in 11% of patients without uterine body extension, but increased to 75% in those with uterine involvement. Average tumor volume in node-negative patients was 49 cc (5-186). Average tumor volume in node-positive patients was 69 cc (8-256). There was a significant association between nodal involvement and both FIGO stage (P = 0.018) and uterine body involvement (P < 0.001), but tumor volume and longitudinal MRI diameter were not statistically significant in unifactor predictors of nodal involvement. In multivariate analysis only uterine body extension, however, was independently related to the risk of nodal involvement. In conclusion, MRI provides noninvasive tumor size evaluation and can also demonstrate invasion of the uterine body that appears to be associated with an increased risk of nodal metastasis. This may provide clinically important prognostic information not available from current FIGO staging.
Similar articles
-
FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):489-93. doi: 10.1016/s0360-3016(02)04521-2. Int J Radiat Oncol Biol Phys. 2003. PMID: 12738325
-
Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent.Int J Gynecol Cancer. 2009 Jul;19(5):912-8. doi: 10.1111/IGC.0b013e3181a58d3f. Int J Gynecol Cancer. 2009. PMID: 19574784
-
Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy.Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):353-9. doi: 10.1016/s0360-3016(02)02705-0. Int J Radiat Oncol Biol Phys. 2002. PMID: 12023139
-
Multimodality Imaging of Uterine Cervical Malignancies.AJR Am J Roentgenol. 2020 Aug;215(2):292-304. doi: 10.2214/AJR.19.21941. Epub 2020 Jun 17. AJR Am J Roentgenol. 2020. PMID: 32551909 Review.
-
Patients with locally advanced cervical cancer should not undergo routine pretreatment surgical staging.Eur J Gynaecol Oncol. 2006;27(2):109-14. Eur J Gynaecol Oncol. 2006. PMID: 16620049 Review.
Cited by
-
Correlation between Neutrophil-to-Lymphocyte Ratio and Pretreatment Magnetic Resonance Imaging and Their Predictive Significance in Cervical Carcinoma Patients Referred for Radiotherapy.J Oncol. 2022 Mar 18;2022:3409487. doi: 10.1155/2022/3409487. eCollection 2022. J Oncol. 2022. PMID: 35342402 Free PMC article.
-
Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology.Eur Radiol. 2011 May;21(5):1102-10. doi: 10.1007/s00330-010-1998-x. Epub 2010 Nov 10. Eur Radiol. 2011. PMID: 21063710
-
The protective role of DMBT1 in cervical squamous cell carcinoma.Kaohsiung J Med Sci. 2019 Dec;35(12):739-749. doi: 10.1002/kjm2.12117. Epub 2019 Aug 9. Kaohsiung J Med Sci. 2019. PMID: 31400059 Free PMC article.
-
Nonsurgical management of cervical cancer: locally advanced, recurrent, and metastatic disease, survivorship, and beyond.Am Soc Clin Oncol Educ Book. 2015:e299-309. doi: 10.14694/EdBook_AM.2015.35.e299. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993189 Free PMC article.
-
The Prognostic Role of Magnetic-Resonance-Imaging-Detected Corpus Invasion in Patients with Cervical Carcinoma Who Underwent Definitive or Adjuvant Pelvic Radiotherapy.Cancers (Basel). 2025 Apr 26;17(9):1449. doi: 10.3390/cancers17091449. Cancers (Basel). 2025. PMID: 40361376 Free PMC article.